Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.
暂无分享,去创建一个
P. Campochiaro | A. Rundle | Roman G. Rubio | J. Heier | L. Feiner | Sarah Gray | Namrata Saroj | W. Murahashi